Apyx Medical Corp financial data

Symbol
APYX on Nasdaq
Location
Clearwater, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 496% % -11%
Quick Ratio 78% % -11%
Debt-to-equity 534% % 92%
Return On Equity -151% % 2.4%
Return On Assets -24% % 41%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38,241,905 shares 10%
Common Stock, Shares, Outstanding 37,819,478 shares 9.2%
Entity Public Float $43,100,000 USD -74%
Common Stock, Value, Issued $38,000 USD 8.6%
Weighted Average Number of Shares Outstanding, Basic 40,748,000 shares 18%
Weighted Average Number of Shares Outstanding, Diluted 34,644,000 shares 0.12%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $47,902,000 USD -1.3%
Research and Development Expense $3,546,000 USD -34%
Operating Income (Loss) $9,505,000 USD 56%
Nonoperating Income (Expense) $4,754,000 USD -1.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $14,259,000 USD 50%
Income Tax Expense (Benefit) $265,000 USD 6%
Net Income (Loss) Attributable to Parent $14,540,000 USD 49%
Earnings Per Share, Basic 0 USD/shares 58%
Earnings Per Share, Diluted 0 USD/shares -74%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $25,135,000 USD -10%
Accounts Receivable, after Allowance for Credit Loss, Current $12,995,000 USD -0.32%
Inventory, Net $9,145,000 USD 1.6%
Assets, Current $48,788,000 USD -6.5%
Property, Plant and Equipment, Net $2,390,000 USD 25%
Operating Lease, Right-of-Use Asset $4,342,000 USD -9.9%
Other Assets, Noncurrent $1,812,000 USD 1.5%
Assets $57,365,000 USD -5.5%
Accounts Payable, Current $3,220,000 USD 68%
Employee-related Liabilities, Current $1,277,000 USD
Accrued Liabilities, Current $7,344,000 USD 0.73%
Contract with Customer, Liability, Current $515,000 USD -51%
Liabilities, Current $10,978,000 USD 15%
Contract with Customer, Liability, Noncurrent $1,216,000 USD -4.3%
Operating Lease, Liability, Noncurrent $4,173,000 USD -9.4%
Other Liabilities, Noncurrent $293,000 USD 46%
Liabilities $51,285,000 USD 3.6%
Retained Earnings (Accumulated Deficit) $87,823,000 USD -20%
Stockholders' Equity Attributable to Parent $5,848,000 USD -47%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6,080,000 USD -46%
Liabilities and Equity $57,365,000 USD -5.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $702,000 USD 89%
Net Cash Provided by (Used in) Financing Activities $25,000 USD
Net Cash Provided by (Used in) Investing Activities $55,000 USD -57%
Common Stock, Shares Authorized 75,000,000 shares 0%
Common Stock, Shares, Issued 37,819,478 shares 9.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $730,000 USD 89%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $32,678,000 USD 77%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,145,000 USD -2.6%
Deferred Tax Assets, Valuation Allowance $20,697,000 USD 26%
Deferred Tax Assets, Gross $22,056,000 USD 22%
Operating Lease, Liability $4,818,000 USD -8.1%
Payments to Acquire Property, Plant, and Equipment $55,000 USD 57%
Lessee, Operating Lease, Liability, to be Paid $6,989,000 USD -10%
Property, Plant and Equipment, Gross $5,341,000 USD 6%
Operating Lease, Liability, Current $393,000 USD 19%
Lessee, Operating Lease, Liability, to be Paid, Year Two $824,000 USD 2.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $797,000 USD 2.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,171,000 USD -15%
Lessee, Operating Lease, Liability, to be Paid, Year Three $852,000 USD 2.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $764,000 USD -11%
Additional Paid in Capital $93,633,000 USD 11%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $138,000 USD -12%
Deferred Tax Assets, Net of Valuation Allowance $1,359,000 USD -14%
Share-based Payment Arrangement, Expense $2,339,000 USD -43%
Interest Expense $4,524,000 USD 479%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%